HIV-1 fitness and macrophages

被引:16
作者
Goodenow, MM
Rose, SL
Tuttle, DL
Sleasman, JW
机构
[1] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA
[2] Univ Florida, Coll Med, Dept Pediat, Div Immunol & Infect Dis, Gainesville, FL 32610 USA
[3] Univ S Florida, Coll Med, Dept Pediat, Div Allergy & Immunol, St Petersburg, FL 33701 USA
[4] Univ S Florida, All Childrens Hosp, St Petersburg, FL 33701 USA
关键词
review; antiretroviral therapy; gag/protease; envelope; tropism; phenotype;
D O I
10.1189/jlb.0403186
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
HIV-1 comprises a collection of closely related, but not identical, viruses or quasispecies. Fitness represents a selective advantage for propagation among populations of organisms competing in a particular environment and is an important characteristic of viruses because of a link between fitness and pathogenesis. Environmental differences based on the type of cell that is targeted for infection or the cell type that produces virus, impact fitness. CD4-expressing cells of lymphocyte or macrophage lineage are the principal host cells for HIV-1, although the milieu in lymphocytes is distinct from the macrophage environment from the perspective of cell half-life and activation, signal transduction and expression of coreceptors, and bioavailability of antiretroviral. drugs. Multiple viral determinants, including entry via envelope glycoproteins, replication by reverse transcriptase, and virion maturation by protease activity, contribute to fitness in different cells and provide targets for current antiretroviral therapies. This review focuses on fitness of HIV-1 in macrophages and examines the impact of protease inhibitors on fitness of quasispecies and an unexplained discordance between fitness and pathogenesis. J. Leukoc. Biol. 74: 657-666; 2003.
引用
收藏
页码:657 / 666
页数:10
相关论文
共 156 条
[101]   KINETICS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE TRANSCRIPTION IN BLOOD MONONUCLEAR PHAGOCYTES ARE SLOWED BY LIMITATIONS OF NUCLEOTIDE PRECURSORS [J].
OBRIEN, WA ;
NAMAZI, A ;
KALHOR, H ;
MAO, SH ;
ZACK, JA ;
CHEN, ISY .
JOURNAL OF VIROLOGY, 1994, 68 (02) :1258-1263
[102]   Immune reconstitution in HIV-1-infected children on antiretroviral therapy: role of thymic output and viral fitness [J].
Ometto, L ;
De Forni, D ;
Patiri, F ;
Trouplin, V ;
Mammano, F ;
Giacomet, V ;
Giaquinto, C ;
Douek, D ;
Koup, R ;
De Rossi, A .
AIDS, 2002, 16 (06) :839-849
[103]  
PARIKH U, 2001, HIV SEQUENCE COMPEND, P191
[104]   CHANGES IN GROWTH-PROPERTIES ON PASSAGE IN TISSUE-CULTURE OF VIRUSES DERIVED FROM INFECTIOUS MOLECULAR CLONES OF HIV-1LAI, HIV-1MAL, AND HIV-1ELI [J].
PEDEN, K ;
EMERMAN, M ;
MONTAGNIER, L .
VIROLOGY, 1991, 185 (02) :661-672
[105]  
Pelchen-Matthews A, 1998, EUR J IMMUNOL, V28, P3639, DOI 10.1002/(SICI)1521-4141(199811)28:11<3639::AID-IMMU3639>3.0.CO
[106]  
2-Q
[107]   Primary and recombinant HIV type 1 strains resistant to protease inhibitors are pathogenic in mature human lymphoid tissues [J].
Penn, ML ;
Myers, M ;
Eckstein, DA ;
Liegler, TJ ;
Hayden, M ;
Mammano, F ;
Clavel, F ;
Deeks, SG ;
Grant, RM ;
Goldsmith, MA .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 (06) :517-523
[108]   CD45: new jobs for an old acquaintance [J].
Penninger, JM ;
Irie-Sasaki, J ;
Sasaki, T ;
Oliveira-dos-Santos, AJ .
NATURE IMMUNOLOGY, 2001, 2 (05) :389-396
[109]   HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time [J].
Perelson, AS ;
Neumann, AU ;
Markowitz, M ;
Leonard, JM ;
Ho, DD .
SCIENCE, 1996, 271 (5255) :1582-1586
[110]   Human immunodeficiency virus type 1 protease genotype predicts immune and viral responses to combination therapy with protease inhibitors (PIs) in PI-naive patients [J].
Perez, EE ;
Rose, SL ;
Peyser, B ;
Lamers, SL ;
Burkhardt, B ;
Dunn, BM ;
Hutson, AD ;
Sleasman, JW ;
Goodenow, MM .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (04) :579-588